Form 4 for NUVB Nuvation Bio Inc.
Accepted 2025-12-03 00:00:00 ET · period of report 2025-12-01 · accession 0001937915-25-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-03 | 2025-12-01 | NUVB | Liu Dongfang | Chief MEDICAL Off | M - OptEx | $2.93 | +150.0K | 168.0K | +833% | +$439.5K |
| D | 2025-12-03 | 2025-12-01 | NUVB | Liu Dongfang | Chief MEDICAL Off | S - Sale+OE | $7.82 | -150.0K | 18.0K | -89% | -$1.17M |
| D | 2025-12-03 | 2025-12-01 | NUVB | Liu Dongfang | Chief MEDICAL Off | M - OptEx | $0.00 | -150.0K | 165.0K | -48% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-12-01 | M | A | 150,000 | $2.93 | 168,000 | D | — | — | |
| 2 | Common | Class A Common Stock | 2025-12-01 | S | D | 150,000 | $7.82 | 18,000 | D | — | — | (F1) Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.80 to $7.855. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-12-01 | M | D | 150,000 | $0.00 | 165,000 | D | $2.93 · — to 2032-08-28 | 150,000 Class A Common Stock | (F2) Option vested as to 25% on the one year anniversary of 8/29/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date |